G. Roccamo

Improving survival with deferiprone treatment in patients with thalassemia major: a prospective multicenter randomised clinical trial under the auspices of the Italian Society for Thalassemia and Hemoglobinopathies.

P. Cianciulli, L. Cuccia, V. Caruso, 2009, Blood cells, molecules & diseases.

The role of anaemia in oxidative and genotoxic damage in transfused β-thalassaemic patients

C. Salpietro, E. Ferro, M. L. La Rosa, 2017, Hematology.

Longitudinal changes in LIC and other parameters in patients receiving different chelation regimens: Data from LICNET

D. Fiorino, A. Filosa, L. Pitrolo, 2018, European journal of haematology.

Deferiprone Versus Sequential Deferiprone-Deferoxamine Treatment in Thalassemia Major: A Five Years Multicenter Randomized Clinical Trial under the Auspices of the Society for the Study of Thalassemia and Hemoglobinopathies (SoSTE).

G. D’Amico, A. Morabito, P. Cianciulli, 2007 .